Paul Maier V - 03 Jan 2025 Form 4 Insider Report for Eton Pharmaceuticals, Inc. (ETON)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ETON	Employee Stock Option (Right to Buy)	Award	$0	+25,000		$0.000000	25,000	03 Jan 2025	Common Stock	25,000	$13.00	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	The shares subject to the option shall vest equally on a quarterly basis over 12 months from the date of grant until fully vested and exercisable on January 3, 2026.

The reporting person has authorized and designated the named person to file this Form 4 on the reporting person's behalf for indefinite duration.